Jayne Gershkowitz, VP, Patient Advocacy at AMICUS THERAPEUTICS INC (FOLD), bought 5,000 shares at $7.00 ($35K) on 2014-08-27, disclosed to the SEC on 2014-08-29.
Scheduled purchase ($35k) by VP, Patient Advocacy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2015-03-24 | $123K | — | Filing → |
| FOLD | SELL | 2014-08-26 | $30K | — | Filing → |
| FOLD | BUY | 2014-08-26 | $30K | — | Filing → |